Evolve Capital
Evolve Capital is a Dallas-based private equity firm founded in 1993 that partners with founder-run businesses with $2-5M EBITDA through leveraged recapitalizations, deploying 100% of its own equity capital across healthcare, manufacturing, and consumer products sectors.
- Company typePrivate
- Founded1993
- HeadquartersDallas, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Evolve Capital does
Evolve Capital is a Dallas-based private equity firm that has been partnering with founder-run businesses through leveraged recapitalizations since 1993. The firm targets companies with $2-5M EBITDA in non-cyclical, asset-light, or regulated verticals, with a stated preference for sectors subject to FDA, CMS, Medicare, Medicaid, and ITAR oversight. Evolve deploys 100% of its own equity capital rather than third-party limited partner funds, which the firm highlights as enabling fast, partner-level decision-making without investment committees.
The firm provides portfolio company founders with partial liquidity at close while retaining a meaningful equity stake for a second bite at exit, and partners with management to add professional executives, build sales processes, fund add-on acquisitions, and expand geographically across multiple states. Documented realized exits include Texas Home Health Agency (33x), D&S Residential Services (9x), Future Food (8.8x), Doctor's Choice Home Care (7.5x), Comfort Keepers (7.2x), Cambridge Home Health Care (5x), Option 1 Nutrition Solutions (5x), Biologos (4.2x), Green Circuits and Mission Critical Electronics (3.5x each), Aspire Home Care (2.4x), and Filling Machines & Systems (2x), for cumulative gross exit proceeds of $500M+.
Deal sourcing is relationship-driven: most investments originate through long-term intermediary relationships with attorneys, lenders, and brokers built over 20+ years, and partners (not associates or analysts) handle all founder communications directly. The 1-10 person team is led by partners Jeff Baker, Ryan Shultz, Matt Becker, and Ben Mackay, with specialized advisors in consumer products (Dave Watts), home health (Sandy Bell), and operations and growth (Andy Greenawalt). The current portfolio includes home health and hospice, residential and day services, emergency services manufacturing, and decontamination and cleaning platforms.
Evolve Capital firmographics
Firmographics- Name
- Evolve Capital
- Legal name
- Evolve Capital
- Website
- https://evolvecapital.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Evolve Capital is a Dallas-based private equity firm founded in 1993 that partners with founder-run businesses with $2-5M EBITDA through leveraged recapitalizations, deploying 100% of its own equity capital across healthcare, manufacturing, and consumer products sectors.
- Ownership category
- akta.pro rank
Evolve Capital industry classification
Industry- Product category
- Private Equity / Leveraged Recapitalization
- NAICS
- Other Financial Investment Activities (5239)
- SIC
- Investors, Nec (6799)
- akta.pro primary industry
- Micro-PE / Lower Middle Market ETA Funds (FSANALAG)
- akta.pro secondary industry
- Platform Buy-and-Build / Roll-Up Buyout (FSANABAI)
Keywords
Where Evolve Capital is headquartered
LocationHeadquarters
- HQ city
- Dallas
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Evolve Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Private Equity Returns: Evolve Capital generates returns through leveraged recapitalizations of entrepreneurial businesses, providing owners with liquidity at close and retaining equity stakes for second bites at exit. The firm invests its own capital and achieves returns upon company exits, with documented multiples ranging from 2x to 33x invested capital across realized investments.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Evolve Capital product offering
Product offeringCore offering
Evolve Capital is a private equity firm that provides leveraged recapitalizations to founder-run, non-cyclical, service or asset-light businesses with $2-5M EBITDA. The firm invests 100% of its own equity capital, enabling rapid investment decisions without committee or LP approval, and structures transactions so owners receive liquidity at close alongside a retained equity stake for a second bite at exit. In between, the firm partners with management on sales process build-out, systems and infrastructure, financing for add-on acquisitions, and multi-state footprint expansion.
Product overview
Evolve Capital is a private equity firm focused exclusively on leveraged recapitalizations of entrepreneurial businesses with $2–5M EBITDA. The firm partners with founders to provide liquidity at close while retaining meaningful equity stake. Evolve Capital's investment services include providing direction, advice, strategic partnerships, building sales teams and processes, financing add-on acquisitions, and supporting multi-state footprint expansion. The portfolio spans multiple sectors including healthcare services (home health, hospice, residential services), manufacturing (PCB assembly, packaging equipment, power products), consumer products (food, in-home care), and business services. Investment criteria focus on non-cyclical, service or asset-light businesses with sustainable EBITDA margins of 10% or more in regulated environments.
Differentiator
Problem solved
Functional benefit
Products and services
- Leveraged Recapitalization Partnership Private equity investment service for founder-run, non-cyclical, service or asset-light businesses with $2-5M EBITDA. Provides owners with liquidity at close alongside a retained equity stake for a second bite at exit, paired with partner-level support on sales team and process build-out, systems and infrastructure enhancement, financing for add-on acquisitions, professional management partnership, and multi-state footprint expansion to maximize exit valuation.
Quantifiable outcome
- 3.5x invested capital return on Green Circuits exit (revenue doubled, EBITDA increased 2.5x over 8 years)
- +4 more outcomes
Companies that use Evolve Capital
Customer profileSegments5 records
Ideal customer profiles1 record
Evolve Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Evolve Capital partnerships and signals
Strategic signalScale indicators3 records
Recent moves7 records
Expansion highlights5 records
Evolve Capital competitors and assessment
Company assessmentDirect peers
- IPI Capital (Innova/Pacific): IPI Capital is a search fund capital provider that funds entrepreneurs acquiring small businesses. Similar to Evolve in its focus on lower middle market, founder-led acquisitions, often with co-investor equity.
- Pacific Lake Partners: Pacific Lake is a search fund sponsor and lower middle market private equity investor that supports entrepreneurs acquiring small, often $2-10M EBITDA businesses. Directly comparable to Evolve Capital in target size, capital base (partner equity), and emphasis on smaller, founder-led transactions.
- Trilogy Search Partners: Trilogy invests in and supports search fund entrepreneurs acquiring and operating lower middle market companies. Comparable to Evolve in its focus on small, founder-run businesses and operator-led value creation.
- Empower Capital (formerly ECA Partners): Empower Capital is a lower middle market private equity firm focused on recapitalizations and management buyouts of small, profitable businesses. Closely comparable to Evolve's recapitalization model and EBITDA sweet spot.
- Oxbow Industries: Oxbow Industries is a holding company that acquires and operates small, profitable industrial and consumer businesses. Comparable to Evolve in its long-hold, owner-friendly approach to lower middle market businesses, though focused on operating ownership rather than recapitalization.
- Prairie Capital: Prairie Capital is a lower middle market private equity firm focused on leveraged recapitalizations and management buyouts of profitable, founder-run businesses — a near-direct model match to Evolve Capital.
- Granite Creek Capital Partners: Granite Creek is a lower middle market private equity firm investing in niche manufacturing, business services, and healthcare companies, often through recapitalizations. Comparable to Evolve in target profile and EBITDA range.
- Long Path Partners: Long Path Partners invests in and acquires small, profitable lower middle market companies, often partnering with founders on recapitalizations. Directly comparable in deal size, structure, and partnership orientation.
- Fulcrum Equity Partners: Fulcrum is a lower middle market private equity firm focused on leveraged recapitalizations and management buyouts of profitable, founder-run businesses. Comparable to Evolve in target profile, EBITDA range, and recap model.
Emerging players
- Health Enterprise Partners: Health Enterprise Partners is a healthcare-focused private equity firm investing in lower middle market healthcare services and technology companies. Comparable to Evolve's healthcare services portfolio (home health, hospice, residential services) and add-on growth strategy.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Evolve Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Evolve Capital leadership team
Management profileNumber of profiles
Profiles11 records
Evolve Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Evolve Capital M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Evolve Capital
What does Evolve Capital do?
Evolve Capital is a private equity firm that provides leveraged recapitalizations to founder-run, non-cyclical, service or asset-light businesses with $2-5M EBITDA. The firm invests 100% of its own equity capital, enabling rapid investment decisions without committee or LP approval, and structures transactions so owners receive liquidity at close alongside a retained equity stake for a second bite at exit. In between, the firm partners with management on sales process build-out, systems and infrastructure, financing for add-on acquisitions, and multi-state footprint expansion.
Is Evolve Capital a public or private company?
Evolve Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Evolve Capital founded?
Evolve Capital was founded in 1993. It employs 1 to 10 people.
Where is Evolve Capital based?
Evolve Capital is headquartered in Dallas, United States, in the North America region.
How does Evolve Capital make money?
One revenue line is on record: private Equity Returns.
Who are Evolve Capital's main competitors?
Direct peers on record are IPI Capital (Innova/Pacific), Pacific Lake Partners, Trilogy Search Partners, Empower Capital (formerly ECA Partners), Oxbow Industries, Prairie Capital, Granite Creek Capital Partners, Long Path Partners and Fulcrum Equity Partners. Health Enterprise Partners is listed as an emerging player.
Does Evolve Capital have an API?
No public API is recorded for Evolve Capital.
What industry is Evolve Capital in?
Evolve Capital's product category is Private Equity / Leveraged Recapitalization. Its primary akta.pro industry code is FSANALAG, Micro-PE / Lower Middle Market ETA Funds, with a secondary code of FSANABAI, Platform Buy-and-Build / Roll-Up Buyout. Its NAICS code is 5239 and its SIC code is 6799.